文档
测试

获取指定药物关联的临床试验列表

websocket测试
POST
/show/medicine_main_drug/getTrialInfo

接口描述

获取指定药物关联的临床试验列表

请求参数

参数名
类型
描述
必填
id
string
药物ID
必填
page_num
int
当前页数量
必填
page_now
int
当前页
必填
cond
int
病症/疗法ID
必填
order
int
排序，1为实验编号正序，2为实验编号倒序，11为临床阶段正序，12为临床阶段倒序，21为完成状态正序，22为完成状态倒序
必填

响应参数

参数名
类型
描述
必填
result
bool
是否成功
必填
msg
string
描述
必填
data
array
返回数组，以下各执不存在时均为null
必填
trial_code
string
试验编号
必填
trial_title
string
试验标题
必填
trial_phase
string
临床阶段
必填
trial_status
string
完成状态
必填
trial_purpose
string
目的
必填
trial_url
string
试验外链
必填
relation
array
相关药物数组
必填
id
int
药物ID，跳转传参使用
必填
name
string
药物名称
必填
cond
array
病症/疗法数组
必填
id
int
病症/疗法ID，筛选传参使用
必填
name
string
病症/疗法名称
必填
count
int
数据总数
必填
page_now
int
当前页
必填
page_num
int
当前页数量
必填

说明 / 示例

{ "result": true, "msg": "ok", "data": [ { "trial_id": 2616, "trial_code": "NCT02208063", "trial_title": "A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial", "trial_phase": "3", "trial_status": "Terminated", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT02208063", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjkdqgpl5dc373f96bde2", "name": "Benzylpenicillin" }, { "id": "drug_awfjk4pbix5dc373ea42622", "name": "Cefazolin" }, { "id": "drug_awfjjwquo75dc373dcdd4cf", "name": "Cloxacillin" }, { "id": "drug_awfjjrv5qj5dc373d4ad2d2", "name": "Daptomycin" }, { "id": "drug_awfjgxawwb5dc373786c612", "name": "Nafcillin" }, { "id": "drug_awfjgjqp525dc37361a288d", "name": "Oxacillin" }, { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" }, { "id": "drug_awfjdymx9b5dc3731545aa6", "name": "Vancomycin" } ], "cond": [ { "id": 708, "name": "Bacteremia" }, { "id": 4810, "name": "Infections, Gram-Positive Bacterial" } ] }, { "trial_id": 2607, "trial_code": "NCT01238796", "trial_title": "A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin", "trial_phase": "1", "trial_status": "Completed", "trial_purpose": "Other", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT01238796", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" } ], "cond": [ { "id": 2642, "name": "End Stage Renal Disease (ESRD)" }, { "id": 1745, "name": "Kidney Diseases" } ] }, { "trial_id": 2614, "trial_code": "NCT00091819", "trial_title": "Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus", "trial_phase": "3", "trial_status": "Completed", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT00091819", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" }, { "id": "drug_awfjdymx9b5dc3731545aa6", "name": "Vancomycin" } ], "cond": [ { "id": 3825, "name": "Skin Diseases, Bacterial" }, { "id": 3551, "name": "Skin Diseases, Infectious" }, { "id": 2106, "name": "Staphylococcal Skin Infections" } ] }, { "trial_id": 2615, "trial_code": "NCT00107978", "trial_title": "Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus", "trial_phase": "3", "trial_status": "Completed", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT00107978", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" }, { "id": "drug_awfjdymx9b5dc3731545aa6", "name": "Vancomycin" } ], "cond": [ { "id": 3825, "name": "Skin Diseases, Bacterial" }, { "id": 3551, "name": "Skin Diseases, Infectious" }, { "id": 2106, "name": "Staphylococcal Skin Infections" } ] }, { "trial_id": 2612, "trial_code": "NCT00107952", "trial_title": "Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus", "trial_phase": "3", "trial_status": "Completed", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT00107952", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" }, { "id": "drug_awfjdymx9b5dc3731545aa6", "name": "Vancomycin" } ], "cond": [ { "id": 2440, "name": "Pneumonia, Bacterial" } ] }, { "trial_id": 2613, "trial_code": "NCT00124020", "trial_title": "Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus", "trial_phase": "3", "trial_status": "Completed", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT00124020", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" }, { "id": "drug_awfjdymx9b5dc3731545aa6", "name": "Vancomycin" } ], "cond": [ { "id": 2440, "name": "Pneumonia, Bacterial" } ] }, { "trial_id": 2617, "trial_code": "NCT02392208", "trial_title": "Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5", "trial_phase": "4", "trial_status": "Completed", "trial_purpose": null, "trial_url": "https://clinicaltrials.gov/ct2/show/NCT02392208", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" } ], "cond": [ { "id": 3560, "name": "End-Stage Renal Disease (ESRD)" }, { "id": 2029, "name": "Hemodialysis-dependent chronic kidney disease (HDD-CKD)" } ] }, { "trial_id": 2606, "trial_code": "NCT02753855", "trial_title": "Pharmacokinetics of Telavancin in Normal and Obese Subjects", "trial_phase": "1", "trial_status": "Completed", "trial_purpose": null, "trial_url": "https://clinicaltrials.gov/ct2/show/NCT02753855", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" } ], "cond": [ { "id": 3474, "name": "Healthy Volunteers" } ] }, { "trial_id": 2608, "trial_code": "NCT00061633", "trial_title": "Phase 2 Trial of TD 6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)", "trial_phase": "2", "trial_status": "Completed", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT00061633", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjkdqgpl5dc373f96bde2", "name": "Benzylpenicillin" }, { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" }, { "id": "drug_awfjdymx9b5dc3731545aa6", "name": "Vancomycin" } ], "cond": [ { "id": 1436, "name": "Abscesses" }, { "id": 585, "name": "Cellulitis" }, { "id": 4810, "name": "Infections, Gram-Positive Bacterial" }, { "id": 746, "name": "Minor burns" }, { "id": 4811, "name": "Ulcers" }, { "id": 1621, "name": "Wound Infections" } ] }, { "trial_id": 2609, "trial_code": "NCT00077675", "trial_title": "Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)", "trial_phase": "2", "trial_status": "Completed", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT00077675", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjkdqgpl5dc373f96bde2", "name": "Benzylpenicillin" }, { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" }, { "id": "drug_awfjdymx9b5dc3731545aa6", "name": "Vancomycin" } ], "cond": [ { "id": 1436, "name": "Abscesses" }, { "id": 585, "name": "Cellulitis" }, { "id": 4810, "name": "Infections, Gram-Positive Bacterial" }, { "id": 746, "name": "Minor burns" }, { "id": 4811, "name": "Ulcers" }, { "id": 1621, "name": "Wound Infections" } ] }, { "trial_id": 2611, "trial_code": "NCT01321879", "trial_title": "Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients", "trial_phase": "2", "trial_status": "Completed", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT01321879", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" } ], "cond": [ { "id": 708, "name": "Bacteremia" }, { "id": 885, "name": "Infection NOS" } ] }, { "trial_id": 2610, "trial_code": "NCT00062647", "trial_title": "Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia", "trial_phase": "2", "trial_status": "Completed", "trial_purpose": "Treatment", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT00062647", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjjwquo75dc373dcdd4cf", "name": "Cloxacillin" }, { "id": "drug_awfjgxawwb5dc373786c612", "name": "Nafcillin" }, { "id": "drug_awfjgjqp525dc37361a288d", "name": "Oxacillin" }, { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" }, { "id": "drug_awfjdymx9b5dc3731545aa6", "name": "Vancomycin" } ], "cond": [ { "id": 1436, "name": "Abscesses" }, { "id": 585, "name": "Cellulitis" }, { "id": 4810, "name": "Infections, Gram-Positive Bacterial" }, { "id": 746, "name": "Minor burns" }, { "id": 4811, "name": "Ulcers" }, { "id": 1621, "name": "Wound Infections" } ] }, { "trial_id": 2620, "trial_code": "NCT02288234", "trial_title": "Telavancin Observational Use Registry (TOUR)", "trial_phase": null, "trial_status": "Completed", "trial_purpose": null, "trial_url": "https://clinicaltrials.gov/ct2/show/NCT02288234", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" } ], "cond": [ { "id": 1444, "name": "Bone and Joint Infections" }, { "id": 4812, "name": "Complicated Bacteremia" }, { "id": 2406, "name": "Endocarditis" }, { "id": 4813, "name": "Gram Positive Infection" }, { "id": 2580, "name": "Hospital Acquired Bacterial Pneumonia" }, { "id": 426, "name": "Skin and Subcutaneous Tissue Bacterial Infections" }, { "id": 2581, "name": "Ventilator Associated Bacterial Pneumonia" } ] }, { "trial_id": 2619, "trial_code": "NCT02013141", "trial_title": "Telavancin Pediatric PK Study (Ages >3 Months to 17 Years)", "trial_phase": "4", "trial_status": "Recruiting", "trial_purpose": "Basic Science", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT02013141", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" } ], "cond": [ { "id": 4810, "name": "Infections, Gram-Positive Bacterial" } ] }, { "trial_id": 2618, "trial_code": "NCT03172793", "trial_title": "Telavancin Pharmacokinetics in Cystic Fibrosis Patients", "trial_phase": "4", "trial_status": "Completed", "trial_purpose": "Other", "trial_url": "https://clinicaltrials.gov/ct2/show/NCT03172793", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" } ], "cond": [ { "id": 470, "name": "Cystic Fibrosis (CF)" } ] }, { "trial_id": 2621, "trial_code": "NCT01130324", "trial_title": "VIBATIV Pregnancy Registry", "trial_phase": null, "trial_status": "Recruiting", "trial_purpose": null, "trial_url": "https://clinicaltrials.gov/ct2/show/NCT01130324", "create_time": "2019-11-08 20:07:38", "relation": [ { "id": "drug_awfjdr4e3f5dc37308a1f62", "name": "Telavancin" } ], "cond": [ { "id": 49, "name": "Pregnancy" } ] } ], "count": 16, "page_now": 1, "page_num": 20 }
上一篇 获取指定药物相关的文献信息列表
nextDoc 获取指定药物关联的专利信息
本文档使用易文档编写, 更新时间: 2019-11-15 14:37